bloc 33rd Square Business Tools - Stephen Scherer 33rd Square Business Tools: Stephen Scherer - All Post
Showing posts with label Stephen Scherer. Show all posts
Showing posts with label Stephen Scherer. Show all posts

Wednesday, January 28, 2015

Autism Speaks Study Finds The Disorder's Genomics More Complex Than Previously Thought

Autism  
The largest-ever autism genome study reveals that the disorder’s genetic underpinnings are even more complex than previously thought. The findings suggest siblings who have autism have different autism-linked genes.






The largest-ever autism genome study reveals that the disorder’s genetic underpinnings are even more complex than previously thought: Most siblings who have autism spectrum disorder (ASD) have different autism-linked genes.

Led by the director of the Autism Speaks MSSNG project (pronounced “missing”), the report made the cover of Nature Medicine.

Simultaneous with publication, the study’s data became part of the historic first upload of approximately 1,000 autism genomes to the Autism Speaks MSSNG portal on the Google Cloud Platform.

Autism Speaks will be making the de-identified data freely available for global research to speed understanding of autism and the development of individualized treatments. The goal of the project’s first phase is to upload 10,000 sequenced autism genomes, together with state-of-the-art, web-based analytic tools.

Related articles
“This is a historic day,” says study leader Stephen Scherer, “as it marks the first time whole genome sequences for autism will be available for research on the MSSNG open-science database. This is an exemplar for a future when open-access genomics will lead to personalized treatments for many developmental and medical disorders.” In addition to leading Autism Speaks’ MSSNG program, Dr. Scherer directs the Centre for Applied Genomics at Toronto’s Hospital for Sick Children and the McLaughlin Centre at the University of Toronto.

"This is an exemplar for a future when open-access genomics will lead to personalized treatments for many developmental and medical disorders."


“By using the cloud to make data like this openly available to researchers around the world, we’re literally breaking down barriers in a way never done before,” says Autism Speaks Chief Science Officer Robert Ring. “As always, our goal at Autism Speaks is to accelerate scientific discovery that will ultimately improve the lives of individuals with autism at home and around the world.” Dr. Ring is among the co-authors of today’s Nature Medicine report.

In its first phase, the MSSNG project aims to make at least 10,000 sequenced autism genomes available for research, along with a "tool box" of state-of-the-art instruments to aide analysis.

In the new study, the researchers sequenced 340 whole genomes from 85 families, each with two children affected by autism. They found that the majority of siblings (69 percent) had little to no overlap in the gene variations known to contribute to autism. Less than a third (31 percent) of the sibling pairs shared the same autism-associated genes.

The findings challenge long-held presumptions. Because autism often runs in families, experts had assumed that siblings with the disorder were inheriting the same autism-predisposing genes from their parents. It now appears this may not be true in most cases.

“We knew that there were many differences in autism, but our recent findings firmly nail that down,” Dr. Scherer says. “We believe that each child with autism is like a snowflake – unique from the other.”

“This means we should not be looking just for suspected autism-risk genes, as is typically done in diagnostic genetic testing,” Dr. Scherer adds. “A full assessment of each individual’s genome is needed to determine how to best use knowledge of genetic factors in personalized autism treatment.” Whole genome sequencing goes far beyond traditional genetic testing to analyze an individual’s complete DNA sequence.



Note - 2016-02-08

Reader Angela Tollersons writes, "Parents of special needs children – and all parents, for that matter – deserve a helping hand from their community, which is why I feel it’s so important that we lend them our support. I believe you and I have a shared goal of spreading information on important health issues."

She suggests the following resources for parents dealing with autism:

Nutrition for ASD Children

http://www.eatright.org/resource/health/diseases-and-conditions/autism/nutrition-for-your-child-with-autism-spectrum-disorder-asd


Coping Mechanisms for Anxiety and ASD

http://www.iidc.indiana.edu/pages/anxiety-and-autism-spectrum-disorders


Why My Son with Autism Needs Routine (With Video)

https://www.autismspeaks.org/blog/2014/09/16/moment-i-got-my-son-autisms-need-routine


The Well Travel Guide for Parents of Autism Spectrum Children

https://travelblog.expedia.ca/autism-travel-guide/



Let’s Have Fun: Activities for Children with Autism

http://www.education.com/magazine/article/10-activities-children-autism/



SOURCE  Autism Speaks


By 33rd SquareEmbed

Tuesday, January 13, 2015

Genetic Determinants of Autism and Cancer Found Using Deep Learning

 Genomics  
Researchers have developed a computational system that mimics the biology of RNA splicing by correlating DNA elements with splicing levels in healthy human tissues. The system can scan DNA and identify damaging genetic variants. This procedure has led to insights into the genetics of autism, cancers, and spinal muscular atrophy.




Scientists and engineers have built a computer model that has uncovered disease-causing mutations in large regions of the genome that previously could not be explored. Their method seeks out mutations that cause changes in ‘gene splicing,’ and has revealed unexpected genetic determinants of autism, colon cancer and spinal muscular atrophy.

Canadian Institute For Advanced Research (CIFAR) senior fellow Brendan Frey, also a professor at the University of Toronto’s Donnelly Centre for Cellular & Biomolecular Research, is the lead author on a paper describing this work, which appeared in the journal of Science Express.

"This work promises to interpret the impact of mutations in a broader region of our genome than has been previously possible."


The paper was co-authored by CIFAR senior fellows Timothy Hughes (University of Toronto) and Stephen Scherer (the Hospital for Sick Children and the University of Toronto) of the Genetic Networks program. Frey is appointed to the Genetic Networks program, and the Neural Computation & Adaptive Perception program.

The research combines the latter groups’ pioneering work on deep learning with novel techniques in genetics.

Most existing methods examine mutations in segments of DNA that encode protein, which Frey refers to as low-hanging fruit. To find mutations outside of those segments, typical approaches such as genome-wide association studies take disease data and compare the mutations of sick patients to those of healthy patients, seeking out patterns. Frey compares the approach to lining up all the books your child likes to read and looking for whether a particular letter occurs more frequently than in other books.

“It doesn’t work, because it doesn’t tell you why your kid likes the book,” he says. “Similarly, genome-wide association studies can’t tell you why a mutation is problematic.”

But looking at splicing can do that. Splicing is important for the vast majority of genes in the human body. When mutations alter splicing, genes may produce no protein, the wrong one or some other problem, which could lead to disease.

Related articles
Frey’s team, which includes researchers from engineering, biology and medicine, developed a computer model that mimics how the cell directs splicing by detecting patterns within DNA sequences, called the ‘splicing code’. The researchers then used their system to examine mutated DNA sequences and determine what effects the mutations would have, effectively scoring each mutation. Unlike existing methods, their technique provides an explanation for the effect of a mutation and can be used to find mutations outside of segments that code for protein.

To develop the computer model, Frey’s team fed experimental data into machine learning algorithms, in order to teach the computer how to examine a DNA sequence and output the splicing pattern.

Their method worked surprisingly well and has led to new discoveries. For example, using DNA sequences from five patients with autism provided by Scherer, the model was able to identify 39 new genes that could be implicated in autism spectrum disorder, a significant increase from about 100 previously known autism genes.

“Brendan's work is groundbreaking because it represents a first serious attempt to decode the portions of that 98 percent of the human genome outside the genes that are typically studied in genetic disease studies,” says Scherer. “This is particularly exciting since it is thought these segments of DNA may contain much of the missing information that we have been looking for in studies like autism.”

The research also sheds light on the genetic mechanisms that lead to spinal muscular atrophy, a leading cause of infant death, and nonpolyposis colorectal cancer.

"Many of us will soon know our complete human genome sequence, which will be like having an encyclopedic guide to ourselves that is written in an alien language,” says Frederick Roth, CIFAR senior fellow and co-director of the program in Genetic Networks. “This work promises to interpret the impact of mutations in a broader region of our genome than has been previously possible.”

SOURCE  Lab Canada Top Image - Frey Lab

By 33rd SquareEmbed